News
Jay Bhattacharya’s tenure as NIH director has seen health disparities research swept up in the Trump administration’s attack ...
The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...
In early June, a MAGA influencer named Chuck Callesto launched a social media assault on Sen. Bill Cassidy, a Louisiana ...
Science evolves as both controlled clinical research and real-world evidence show us how to use health care technologies to ...
The reshaping of the CDC's vaccine advisory panel has continued, with the apparent barring of reps of medical associations ...
This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.
Senators ignored RFK Jr.'s proposal to create a chronic disease agency called the Administration for a Healthy America.
Senators from both parties endorsed a $400 million increase to the budget of the National Institutes of Health on Thursday ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...
U.S. kindergarten vaccination rates inched down again last year and the share of children with exemptions rose to an all-time ...
The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results